Summary:
The purpose of this study is to compare the efficacy of BHV-4157 versus placebo in subjects with Obsessive Compulsive Disorder (OCD).
Qualified Participants Must:
• Be 18-65 years old, diagnosed with OCD for at least 1 year
•
Subjects must be currently experiencing non-response or inadequate response to their current Standard of Care (SOC) medication
Qualified Participants May Receive:
Compensation for time and travel, may receive investigational medication or placebo.